Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock Options (Tables)

Stock Options (Tables)

3 Months Ended

Feb. 28, 2013

Share Based Compensation Arrangement by Share Based Payment Award [Line Items]

Significant option groups outstanding and exercisable option and its price and contractual life

Significant option groups exercisable at February 28, 2013 and related price and contractual life information are as follows:


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price

$0.42 to $1.00		7,500		2.15	$	0.78		7,500	$	0.78
$1.01 to $ 2.00		529,259		7.57	$	1.69		516,763	$	1.69
$2.01 to $ 3.00		600,500		6.82	$	2.50		408,014	$	2.58
$3.01 to $ 4.00		40,589		0.10	$	3.34		40,589	$	3.34

		1,177,848		6.90	$	2.15		972,866	$	2.12

Summary of non-vested options

A summary of the status of the Company’s non-vested shares as of February 28, 2013, and changes during the three months ended February 28, 2013, is presented below:


	Shares			Weighted Average Grant-Date Fair Value

Non-vested at November 30, 2012		251,403		$	1.77

Granted		8,500			1.68
Vested		(49,089	)		1.50
Forfeited		(5,832	)		1.96

Non-vested at February 28, 2013		204,982		$	1.83

Service-based vesting condition options [Member]

Share Based Compensation Arrangement by Share Based Payment Award [Line Items]

Fair value of options granted

Variables used to determine the fair value of the options granted for the three months ended February 28, 2013 and February 29, 2012 are as follows:


	February 28, 2013			February 29, 2012
Weighted average values:
Expected dividends		0	%		0	%
Expected volatility		113.8	%		111.5	%
Risk free interest rate		.80	%		.93	%
Expected life		5.0 years			5.8 years

Range of expected volatilities for options

The range of expected volatilities for options issued during the three months ended February 28, 2013 and February 29, 2012 are as follows:


February 28, 2013		February 29, 2012

112.9% - 114.9%		111.3% - 113.3%

Stock option activity for options

Stock option activity for the three months ended February 28, 2013, was as follows:


	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2012		1,183,098		$	2.15		7.12	$	580,730

Granted		8,500			2.09
Exercised		—			—
Expired/forfeited		(13,750	)		1.94


Outstanding at February 28, 2013		1,177,848		$	2.15		6.90	$	233,259

Exercisable at February 28, 2013		972,866		$	2.12		7.11	$	224,577

Performance and market-based vesting condition options [Member]

Share Based Compensation Arrangement by Share Based Payment Award [Line Items]

Fair value of options granted

Variables used to determine the fair value of options with performance-based and market-based vesting conditions granted during the three months ended February 29, 2012 are as follows:


	February 29, 2012
Weighted average values:
Expected dividends		0	%
Expected volatility		112.3	%
Risk free interest rate		.90	%
Expected life		5.5 years

Range of expected volatilities for options

The range of expected volatilities for performance-based and market-condition options issued during the three months ended February 29, 2012 are as follows:

February 29, 2012

111.3% - 113.5%

Stock option activity for options

Stock option activity for options with performance-based and market-based conditions for the three months ended February 28, 2013, was as follows:


	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value

Outstanding at November 30, 2012		640,000	$	1.74		8.83	$	511,600

Granted		—		—
Exercised		—		—
Expired/forfeited		—		—


Outstanding at February 28, 2013		640,000	$	1.74		8.58	$	230,000

Exercisable at February 28, 2013		—		—		—		—

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References + Details